On September 20, 2012, a team of specialists appointed by the Jiangsu Food and Drug Administration conducted site inspection at the Academy of Military Medical Sciences to audit the experimental documents for APL-1202 as a procedural requirement by the CFDA. The inspection was completed without any findings.
